InvestorsObserver
×
News Home

Will Phathom Pharmaceuticals Inc (PHAT) Outperform the Rest of the Stocks in the Healthcare Sector?

Friday, October 27, 2023 11:06 AM | InvestorsObserver Analysts

Mentioned in this article

Will Phathom Pharmaceuticals Inc (PHAT) Outperform the Rest of the Stocks in the Healthcare Sector?

Phathom Pharmaceuticals Inc (PHAT) is near the top in its sector according to InvestorsObserver. PHAT gets an overall rating of 58. That means it scores higher than 58% of stocks. Phathom Pharmaceuticals Inc gets a 71 rank in the Healthcare sector. Healthcare is number 6 out of 11 sectors.

Overall Score - 58
PHAT has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on PHAT!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 58 would rank higher than 58 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Phathom Pharmaceuticals Inc Stock Today?

Phathom Pharmaceuticals Inc (PHAT) stock is down -1% while the S&P 500 has gained 0.2% as of 11:06 AM on Friday, Oct 27. PHAT is down -$0.09 from the previous closing price of $8.52 on volume of 134,280 shares. Over the past year the S&P 500 is higher by 8.88% while PHAT is down -18.06%. PHAT lost -$4.39 per share the over the last 12 months. Click Here to get the full Stock Report for Phathom Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App